EA201170220A1 - Лечение ревматоидного артрита бета-дефенсинами млекопитающих - Google Patents
Лечение ревматоидного артрита бета-дефенсинами млекопитающихInfo
- Publication number
- EA201170220A1 EA201170220A1 EA201170220A EA201170220A EA201170220A1 EA 201170220 A1 EA201170220 A1 EA 201170220A1 EA 201170220 A EA201170220 A EA 201170220A EA 201170220 A EA201170220 A EA 201170220A EA 201170220 A1 EA201170220 A1 EA 201170220A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- defensins
- treatment
- rheumatoid arthritis
- beta
- mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Настоящее изобретение относится к лечению ревматоидного артрита бета-дефенсинами млекопитающих.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08160761 | 2008-07-18 | ||
EP09160448 | 2009-05-15 | ||
PCT/EP2009/059255 WO2010007168A2 (en) | 2008-07-18 | 2009-07-17 | Treatment of rheumatoid arthritis with mammal beta defensins |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201170220A1 true EA201170220A1 (ru) | 2011-08-30 |
Family
ID=41530821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170220A EA201170220A1 (ru) | 2008-07-18 | 2009-07-17 | Лечение ревматоидного артрита бета-дефенсинами млекопитающих |
Country Status (17)
Country | Link |
---|---|
US (2) | US8232248B2 (ru) |
EP (1) | EP2320928B1 (ru) |
JP (1) | JP2011528334A (ru) |
KR (1) | KR20110031970A (ru) |
CN (1) | CN102159234A (ru) |
AP (1) | AP2011005536A0 (ru) |
AR (1) | AR072525A1 (ru) |
AU (1) | AU2009272683A1 (ru) |
BR (1) | BRPI0915778A2 (ru) |
CA (1) | CA2730666A1 (ru) |
EA (1) | EA201170220A1 (ru) |
IL (1) | IL210716A0 (ru) |
MX (1) | MX2011000567A (ru) |
NZ (1) | NZ590469A (ru) |
TW (1) | TW201004639A (ru) |
WO (1) | WO2010007168A2 (ru) |
ZA (1) | ZA201100460B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100016232A1 (en) * | 2008-07-18 | 2010-01-21 | Novozymes A/S | Treatment Of Inflammatory Diseases With Mammal Beta Defensins |
AR072032A1 (es) * | 2008-07-18 | 2010-07-28 | Novozymes As | Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos |
KR101257228B1 (ko) * | 2010-06-16 | 2013-04-29 | 주식회사 나이벡 | 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물 |
AU2012242479B2 (en) | 2011-04-15 | 2015-04-16 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acetylglucosamine nanofibers |
EP2729159B1 (en) | 2011-07-08 | 2017-05-24 | Defensin Therapeutics ApS | Oral treatment of inflammatory bowel disease |
WO2013026794A1 (en) | 2011-08-19 | 2013-02-28 | Novozymes | Novel immunomodulatory peptide |
KR102631542B1 (ko) * | 2018-03-14 | 2024-02-01 | 서울대학교산학협력단 | 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도 |
KR102244161B1 (ko) * | 2018-08-31 | 2021-04-26 | 주식회사 나이벡 | 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
KR20050089827A (ko) * | 2002-12-19 | 2005-09-08 | 이츠차크 힐만 | 항균성 펩티드 억제물을 통한 질환 치료 |
GB0514482D0 (en) | 2005-07-14 | 2005-08-17 | Ares Trading Sa | Protein |
WO2007081486A2 (en) | 2005-12-15 | 2007-07-19 | Ventria Bioscience | Oral administration of defensins to treat intestinal diseases |
WO2007087557A2 (en) | 2006-01-24 | 2007-08-02 | University Of Maryland Biotechnology Institute | Surface-layer protein coated microspheres and uses thereof |
CA2704726A1 (en) | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a defensin peptide as a therapeutic agent |
US20100016232A1 (en) * | 2008-07-18 | 2010-01-21 | Novozymes A/S | Treatment Of Inflammatory Diseases With Mammal Beta Defensins |
AR072032A1 (es) | 2008-07-18 | 2010-07-28 | Novozymes As | Tratamiento de enfermedades inflamatorias del intestino con beta defensinas de mamiferos |
-
2009
- 2009-07-17 MX MX2011000567A patent/MX2011000567A/es not_active Application Discontinuation
- 2009-07-17 AR ARP090102742A patent/AR072525A1/es not_active Application Discontinuation
- 2009-07-17 US US12/504,920 patent/US8232248B2/en active Active
- 2009-07-17 BR BRPI0915778A patent/BRPI0915778A2/pt not_active IP Right Cessation
- 2009-07-17 EP EP09780793A patent/EP2320928B1/en active Active
- 2009-07-17 AP AP2011005536A patent/AP2011005536A0/xx unknown
- 2009-07-17 JP JP2011517956A patent/JP2011528334A/ja active Pending
- 2009-07-17 CN CN200980136396XA patent/CN102159234A/zh active Pending
- 2009-07-17 EA EA201170220A patent/EA201170220A1/ru unknown
- 2009-07-17 KR KR1020117002949A patent/KR20110031970A/ko not_active Application Discontinuation
- 2009-07-17 NZ NZ590469A patent/NZ590469A/xx not_active IP Right Cessation
- 2009-07-17 WO PCT/EP2009/059255 patent/WO2010007168A2/en active Application Filing
- 2009-07-17 AU AU2009272683A patent/AU2009272683A1/en not_active Abandoned
- 2009-07-17 CA CA2730666A patent/CA2730666A1/en not_active Abandoned
- 2009-07-20 TW TW098124400A patent/TW201004639A/zh unknown
-
2011
- 2011-01-18 IL IL210716A patent/IL210716A0/en unknown
- 2011-01-18 ZA ZA2011/00460A patent/ZA201100460B/en unknown
-
2012
- 2012-07-09 US US13/544,237 patent/US20120309686A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2730666A1 (en) | 2010-01-21 |
IL210716A0 (en) | 2011-03-31 |
TW201004639A (en) | 2010-02-01 |
WO2010007168A2 (en) | 2010-01-21 |
AU2009272683A1 (en) | 2010-01-21 |
JP2011528334A (ja) | 2011-11-17 |
AR072525A1 (es) | 2010-09-01 |
US20100016231A1 (en) | 2010-01-21 |
MX2011000567A (es) | 2011-02-23 |
AP2011005536A0 (en) | 2011-02-28 |
KR20110031970A (ko) | 2011-03-29 |
WO2010007168A3 (en) | 2010-06-17 |
ZA201100460B (en) | 2012-09-26 |
BRPI0915778A2 (pt) | 2019-09-24 |
US8232248B2 (en) | 2012-07-31 |
NZ590469A (en) | 2012-08-31 |
EP2320928B1 (en) | 2012-11-07 |
CN102159234A (zh) | 2011-08-17 |
US20120309686A1 (en) | 2012-12-06 |
EP2320928A2 (en) | 2011-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201170220A1 (ru) | Лечение ревматоидного артрита бета-дефенсинами млекопитающих | |
CY1121862T1 (el) | Αντισωματα anti-phf-tau και χρησεις αυτων | |
EA201170219A1 (ru) | Лечение воспалительных заболеваний кишечника бета-дефенсинами млекопитающих | |
CR20120297A (es) | Espironucleósidos uracílicos oxetánicos | |
EA201290300A1 (ru) | Сшиваемая полимерная композиция и кабель с улучшенными электрическими свойствами | |
EA201270619A1 (ru) | Применение бетанехола для лечения ксеростомии | |
MX340831B (es) | Composiciones pesticidas. | |
BRPI0918648A2 (pt) | anticorpos multiespecíficos | |
MA32939B1 (fr) | Composes organiques | |
MA32938B1 (fr) | Composes organiques | |
UY34472A (es) | Derivados modificados de 4-fenil-piridina | |
CR20130045A (es) | Compuestos terapéuticos | |
UY34696A (es) | Hojuela de múltiples capas con alto nivel de codificación | |
EA201791693A1 (ru) | Гетеродимерные иммуноглобулины | |
EA201390274A1 (ru) | Борсодержащие малые молекулы | |
GB0917002D0 (en) | Improved shigella blebs | |
EA201290295A1 (ru) | Специфичные к рецептору меланокортина-1 линейные пептиды | |
UY34119A (es) | Montaje machihembrado de fijación | |
ES2530730T3 (es) | Complejo hidrohalogenuro-agomelatina y preparación del mismo | |
MY161868A (en) | Anti-bv8 antibodies and uses thereof | |
SMT201500264B (it) | Mutanti della frataxina | |
IN2012DN04968A (ru) | ||
CL2011001427A1 (es) | Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras. | |
BR112014014896A2 (pt) | nova combinação | |
FR2941115B1 (fr) | Codage de points d'une courbe elliptique |